The transplant of the genetically modified pig heart on Sept. 20 is reportedly the second-ever in the world, according to a Sept. 22 news release. The first also took place at the Baltimore-based medical center in 2022.
The transplant recipient was 58, and had been diagnosed with terminal heart disease prior to the operation. He is reportedly in recovery and communicating well with family and clinicians, the release stated.
The pig’s heart was genetically modified to promote immune system acceptance in humans. Studies continue to be conducted by other systems, including NYU Langone, as well on the sustainability of pig organs transplanted into human patients.
“This transplant is another remarkable achievement for medicine and humanity that would not have been possible without the close relationship between University of Maryland Medical Center and our University of Maryland School of Medicine partners,” Bert O’Malley, MD, president and CEO of the University of Maryland Medical Center said in the release.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
